The data included in this article are associated with the article entitled "DNA-damage-induced apoptosis suppressor (DDIAS) is upregulated via ERK5/MEF2B signaling and promotes β-catenin- . Quantitative RT-PCR data revealed that genetic or pharmacological inhibition of extracellular signalregulated kinase 5 (ERK5) suppresses DDIAS transcription in response to epidermal growth factor (EGF) in Hela cells. p300 did not interact with myocyte enhancer factor 2B (MEF2B), a downstream target of ERK5 and affect transcription of DDIAS. Moreover, DDIAS transcription is activated by ERK5/MEF2B signaling on EGF exposure in the non-small cell lung cancer cells (NSCLC) NCI-H1703 and NCI-H1299. DDIAS knockdown suppresses lung cancer cell invasion by decreasing β-catenin protein level on EGF exposure.
a b s t r a c t
The data included in this article are associated with the article entitled "DNA-damage-induced apoptosis suppressor (DDIAS) is upregulated via ERK5/MEF2B signaling and promotes β-cateninmediated invasion" (J.Y. Im, S.H. Yoon, B.K. Kim, H.S. Ban, K.J. Won, K. S. Chung, K.E. Jung, M. Won) [1] . Quantitative RT-PCR data revealed that genetic or pharmacological inhibition of extracellular signalregulated kinase 5 (ERK5) suppresses DDIAS transcription in response to epidermal growth factor (EGF) in Hela cells. p300 did not interact with myocyte enhancer factor 2B (MEF2B), a downstream target of ERK5 and affect transcription of DDIAS. Moreover, DDIAS transcription is activated by ERK5/MEF2B signaling on EGF exposure in the non-small cell lung cancer cells (NSCLC) NCI-H1703 and NCI-H1299. DDIAS knockdown suppresses lung cancer cell invasion by decreasing β-catenin protein level on EGF exposure. The data provide evidence that DDIAS is a potential therapeutic target of lung cancer.
Data
DDIAS is highly expressed in lung cancers and is involved in cisplatin resistance [2, 3] . In HeLa cells, genetic and pharmacological inhibition of MEK/ERK5 suppressed EGF-induced DDIAS transcription, whereas ERK5 overexpression increased DDIAS mRNA level ( Fig. 1) . DDIAS knockdown dramatically decreased β-catenin protein level in HeLa cells (Fig. 2) . Consistent with data in HeLa cells, inhibition of ERK5 suppressed DDIAS transcription on EGF exposure in lung cancer cell lines (Fig. 3 ). In addition, MEF2B knockdown reduced EGF-induced DDIAS expression in lung cancer cells (Fig. 4) . Furthermore, DDIAS knockdown inhibited β-catenin accumulation and lung cancer cell invasion (Fig. 5 ).
Experimental design, materials and methods

Cell culture and transfection
HeLa cells were cultured in Dulbecco's modified Eagle's medium and non-small cell lung cancer cell, NCI-H1703 and NCI-H1299 cells were cultured in RPMI-1640 containing 10% fetal bovine serum (FBS), 50 U/mL of penicillin, and 50 μg/mL of streptomycin (Invitrogen, Carlsbad, CA, USA) in an incubator at 37°C and 5% CO 2 . Knockdown and overexpression of target genes experiment were performed as described [1] . Cells were transiently transfected with HA-ERK5, HA-p300, Flag-DDIAS or HA-β-catenin using Turbofect (ThermoScientific, Rockford, IL) [4] .
RT-PCR
Total RNA extraction and Real-time PCR were performed as described [1] . The cycling conditions were 95°C for 15 min and 40 cycles of 95°C for 15 s, 55°C for 15 s and 72°C for 15 s. All reactions were performed in triplicate and normalized to GAPDH as an internal control. The values are presented as the mean 7S.E.M. Overexpression of HA-ERK5 or Myc-MEF2B has no effect on EGF-induced NFAT promoter activity. Cells were transfected with HA-ERK5, Myc-MEF2B or HA-NFATc1 and NFATluciferase reporter construct (NFAT-Luc) together. **Po 0.01 vs Vec/Con. NS, no significance. (E) p300 does not interact with MEF2B. HeLa cells were transfected with HA-p300 and treated with 100 ng/ml EGF for 3 h. Immunoprecipitation assays were performed using anti-HA and detected using an anti-MEF2B antibody. 
Co-immunoprecipitation assays
Co-immunoprecipitation assay was performed as previously described [5] . Cell lysates were immunoprecipitated with agarose-conjugated anti-HA antibody. Then, Western blot analyses were carried out using antibodies to peroxidase-conjugated anti-HA or anti-MEF2B antibodies.
Immunocytochemistry
Immunocytochemistry analysis was performed as described [1] . The fixed cells were incubated with anti-β-catenin antibody in 1% BSA solutions. Cells were then incubated with fluoresceinconjugated secondary antibodies (FITC, Santa Cruz). Finally, the cells were counterstained with DAPI to label nuclei and were then analyzed with a fluorescence microscope (LSM5 Live DuoScan, Zeiss).
Invasion assay
Invasion assay was performed as described [1] . Serum-starved cells (1 Â 10 5 ) were seeded in a Matrigel-coated chamber (BD Biosciences, Palo Alto, CA, USA) with 8.0-μm pores (Corning) with or without 100 ng/ml EGF. More than five views were analyzed under a light microscope. All experiments were performed twice in triplicate.
